Advertisement Celera's CFO resigns - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Celera’s CFO resigns

Celera, a provider of personalized disease management services, has reported that its CFO, Joel Jung, has resigned from the company to pursue other opportunities.

The company has appointed Ugo DeBlasi as its new CFO. In this position, Mr DeBlasi will provide leadership to the Celera finance, investor relations and information technology function, and he will report to Kathy Ordonez, Celera’s CEO.

Mr DeBlasi previously worked for Applera. He served as the chief accounting officer for a total of eight years during his tenure with Applera. For the last five years, he held the position of vice president and controller reporting to the CFO.

Ms Ordonez said: “I am delighted that Ugo has joined us as CFO and look forward to making use of his financial and leadership skills, as well as the knowledge of our business he gained by working with us closely for many years in the past.”